Suppr超能文献

分子快照显示了吉尔吉斯斯坦结核分枝杆菌种群结构和耐药性。

Molecular snapshot of Mycobacterium tuberculosis population structure and drug-resistance in Kyrgyzstan.

机构信息

Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute, St. Petersburg, Russia.

出版信息

Tuberculosis (Edinb). 2013 Sep;93(5):501-7. doi: 10.1016/j.tube.2013.05.008. Epub 2013 Jul 24.

Abstract

Kyrgyzstan is a post-Soviet country in Central Asia marked with high incidence and mortality rates of tuberculosis (TB). The present study provided first assessment of Mycobacterium tuberculosis population structure and drug-resistance in civilian population here. The collection included 103 M. tuberculosis DNA samples subjected to the analysis of rifampin and isoniazid resistance mutations and spoligotyping. The major spoligotype-defined families were Beijing (n = 62), T (n = 14), LAM (n = 9), Ural-2 (n = 6) and Ural-1 (n = 3). Genotypically, 20 isolates were RIF-resistant, 28 were INH-resistant, 17 were multidrug-resistant. Drug resistant isolates were more prevalent among Beijing than non-Beijing groups (P = 0.03). The predominance of the mainly "Russian" spoligotypes among the non-Beijing strains (LAM-RUS and Ural-1) in this study along with previously demonstrated prevalence of the Russia-specific subtype of the Beijing family in Kyrgyz prison (Mokrousov et al., 2009) suggest that the current population structure of M. tuberculosis in Kyrgyzstan has been mainly formed within the course of the 20th century when the country was a part of the Russian Empire and Soviet Union. On the other hand, a prevalence of the Asia-specific Ural-2 type in the oldest age group (68-85 years old; P < 0.0001) may present a heritage of the more distant historical events. In summary, we suggest: (i) a clear shift of the local M. tuberculosis population structure during the last 100 years and (ii) a critical impact of the Beijing genotype on the current situation with drug resistant TB in Kyrgyzstan.

摘要

吉尔吉斯斯坦是中亚的一个后苏联国家,结核病(TB)的发病率和死亡率都很高。本研究首次评估了这里的平民人群中结核分枝杆菌的种群结构和耐药性。该研究共收集了 103 份结核分枝杆菌 DNA 样本,对利福平(RIF)和异烟肼(INH)耐药突变和 spoligotyping 进行了分析。主要 spoligotype 定义的家族有北京家族(n=62)、T 家族(n=14)、LAM 家族(n=9)、Ural-2 家族(n=6)和 Ural-1 家族(n=3)。基因型上,20 个分离株为 RIF 耐药,28 个分离株为 INH 耐药,17 个分离株为耐多药。耐药分离株在北京家族比非北京家族更常见(P=0.03)。本研究中,非北京家族的主要“俄罗斯” spoligotype(LAM-RUS 和 Ural-1)占主导地位,而此前在吉尔吉斯斯坦监狱中已证实存在北京家族的俄罗斯特定亚型(Mokrousov 等人,2009 年),这表明目前吉尔吉斯斯坦结核分枝杆菌的种群结构主要是在 20 世纪形成的,当时该国是俄罗斯帝国和苏联的一部分。另一方面,最古老年龄组(68-85 岁;P<0.0001)中 Ural-2 型的流行可能代表了更久远历史事件的传承。总之,我们提出以下建议:(i)过去 100 年来,当地结核分枝杆菌种群结构发生了明显变化,(ii)北京基因型对吉尔吉斯斯坦耐多药结核现状有重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验